Aldeyra Therapeutics, Inc. (ALDX) stock
ALDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.64+0.01 (+2.17%)
Close on Nov 13, 2026Market cap $38.84MP/E –Yield –
Aldeyra Therapeutics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2021 | Sep 30, 2021 | -$15.37M | – |
| Q2 FY2021 | Jun 30, 2021 | -$14.48M | – |
| Q1 FY2021 | Mar 31, 2021 | -$10.76M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.32M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.03M | – |
| Q1 FY2020 | Mar 31, 2020 | -$9.57M | – |
| Q3 FY2019 | Sep 30, 2019 | -$18.99M | – |
| Q2 FY2019 | Jun 30, 2019 | -$13.71M | – |
| Q1 FY2019 | Mar 31, 2019 | -$17.41M | – |
See a number that looks wrong?